• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舌鳞状细胞癌的恶性组织学分级

Histological grading of malignancy in squamous cell carcinoma of the oral tongue.

作者信息

Holm L E, Lundquist P G, Silfverswärd C, Sobin A

出版信息

Acta Otolaryngol. 1982 Jul-Aug;94(1-2):185-92. doi: 10.3109/00016488209128904.

DOI:10.3109/00016488209128904
PMID:7124386
Abstract

A system for histological grading of malignancy was applied to ninety-five squamous cell carcinomas from the anterior 2/3 of the tongue. Three parameters relating to the tumour cell population and three parameters relating to the tumour-host relationship were evaluated. The expected 5-year survival expressed as % survivors was 88% for patients with tumours having total malignancy scores of less than 13 points. 65% for 13-16 and 44% for patients with tumours having scores of more than 16. The prognostic significance for 5-year survival was statistically valid for the three different groups of malignancy scoring. The conventional classification according to mode of differentiation did not give equally good correlations for survival or occurrence of metastases. For the evaluation of the biological behaviour of lingual carcinomas, histological grading of malignancy is a better method.

摘要

一种恶性肿瘤组织学分级系统应用于95例来自舌前三分之二的鳞状细胞癌。评估了与肿瘤细胞群体相关的三个参数以及与肿瘤-宿主关系相关的三个参数。总恶性评分为13分以下的肿瘤患者,以存活百分比表示的预期5年生存率为88%;评分为13 - 16分的患者为65%;评分超过16分的患者为44%。三种不同恶性评分组对5年生存率的预后意义在统计学上是有效的。根据分化模式的传统分类在生存率或转移发生率方面没有给出同样好的相关性。对于评估舌癌的生物学行为,恶性肿瘤组织学分级是一种更好的方法。

相似文献

1
Histological grading of malignancy in squamous cell carcinoma of the oral tongue.舌鳞状细胞癌的恶性组织学分级
Acta Otolaryngol. 1982 Jul-Aug;94(1-2):185-92. doi: 10.3109/00016488209128904.
2
Malignancy grading in oral squamous cell carcinoma. I. Squamous cell carcinoma of the tongue and floor of mouth: histologic grading in the clinical evaluation.口腔鳞状细胞癌的恶性分级。I. 舌和口底的鳞状细胞癌:临床评估中的组织学分级
J Oral Pathol. 1986 Mar;15(3):162-8. doi: 10.1111/j.1600-0714.1986.tb00599.x.
3
Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis.口腔舌鳞状细胞癌的临床、组织学和细胞角蛋白特征与预后的相关性
Int J Surg Pathol. 2007 Oct;15(4):376-83. doi: 10.1177/1066896907304992.
4
The importance of stromal inflammation in squamous cell carcinoma of the tongue.舌鳞状细胞癌中基质炎症的重要性。
J Oral Pathol Med. 2012 May;41(5):379-83. doi: 10.1111/j.1600-0714.2011.01107.x. Epub 2011 Nov 16.
5
[The morphological criteria and prognosis of regional metastases and treatment outcomes in tongue cancer].[舌癌区域转移的形态学标准、预后及治疗结果]
Stomatologiia (Mosk). 1990 Nov-Dec;69(6):42-4.
6
[Correlation between histological grading of malignancy of squamous cell carcinoma of the tongue (by modified Willén's method) and the incidence of cervical lymph node metastasis].[舌鳞状细胞癌恶性程度的组织学分级(采用改良的威伦方法)与颈部淋巴结转移发生率之间的相关性]
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):34-41.
7
Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome.30 岁以下患者的口腔舌部鳞状细胞癌:临床病理特征和结局。
Clin Otolaryngol. 2010 Aug;35(4):307-12. doi: 10.1111/j.1749-4486.2010.02164.x.
8
Clinical-pathological parameters in squamous cell carcinoma of the tongue.舌鳞状细胞癌的临床病理参数
Braz Dent J. 2003;14(1):22-5. doi: 10.1590/s0103-64402003000100004.
9
[Is microvascular density an independent prognostic factor in squamous cell carcinoma of the tongue?].[微血管密度是舌鳞状细胞癌的独立预后因素吗?]
Acta Otorrinolaringol Esp. 2007 Oct;58(8):341-6.
10
Clinicopathological evaluation and survival of patients with squamous cell carcinoma of the tongue.舌鳞状细胞癌患者的临床病理评估与生存情况
Med Oral Patol Oral Cir Bucal. 2018 Sep 1;23(5):e579-e587. doi: 10.4317/medoral.22421.

引用本文的文献

1
Worst pattern of invasion in oral squamous cell carcinoma is an independent prognostic factor.口腔鳞状细胞癌最严重的浸润模式是一个独立的预后因素。
J Oral Biol Craniofac Res. 2022 Nov-Dec;12(6):771-776. doi: 10.1016/j.jobcr.2022.08.027. Epub 2022 Sep 8.
2
Prognostic factors and related complications/sequalae of squamous cell carcinoma located in the gingivobuccal complex.位于龈颊复合体的鳞状细胞癌的预后因素及相关并发症/后遗症。
World J Surg Oncol. 2022 Jul 26;20(1):240. doi: 10.1186/s12957-022-02708-w.
3
Immunohistochemical expression of p53 and its clinicopathological correlation with modified Anneroth's histological grading system.
p53的免疫组织化学表达及其与改良Anneroth组织学分级系统的临床病理相关性
J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):29-35. doi: 10.4103/0973-029X.180922.
4
Variable course of progression of oral cavity and oropharyngeal carcinoma in young adults.年轻成年人口腔和口咽癌的进展过程多变。
Contemp Oncol (Pozn). 2013;17(3):286-90. doi: 10.5114/wo.2013.35279. Epub 2013 Jun 28.
5
Relationships of cervical lymph node metastasis to histopathological malignancy grade, tumor angiogenesis, and lymphatic invasion in tongue cancer.舌癌中颈淋巴结转移与组织病理学恶性程度、肿瘤血管生成和淋巴管浸润的关系。
Odontology. 2010 Jul;98(2):153-9. doi: 10.1007/s10266-010-0131-6. Epub 2010 Jul 23.
6
Prognostic factors for loco-regional failure in early stage (I and II) squamous cell carcinoma of the gingivobuccal complex.牙龈-颊黏膜复合体早期(I 期和 II 期)鳞状细胞癌局部区域失败的预后因素。
Eur Arch Otorhinolaryngol. 2010 Jul;267(7):1135-40. doi: 10.1007/s00405-009-1201-7. Epub 2010 Jan 12.
7
Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for stage I tongue carcinomas.恶性肿瘤分级系统、DNA含量、p53及血管生成对Ⅰ期舌癌的预测价值
J Clin Pathol. 1999 Jan;52(1):35-40. doi: 10.1136/jcp.52.1.35.
8
Vimentin in oral squamous cell carcinoma.波形蛋白与口腔鳞状细胞癌
Eur Arch Otorhinolaryngol. 1993;250(2):105-9. doi: 10.1007/BF00179308.
9
DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.T1和T2期口腔癌的DNA含量、恶性分级及预后
Br J Cancer. 1987 Nov;56(5):647-52. doi: 10.1038/bjc.1987.260.
10
Prognostic implications of DNA ploidy in squamous cell carcinomas of the tongue assessed by flow cytometry.通过流式细胞术评估舌鳞状细胞癌中DNA倍性的预后意义。
J Cancer Res Clin Oncol. 1990;116(1):83-6. doi: 10.1007/BF01612644.